Press Releases from MorphoSys (1 total)
direct/ MorphoSys Signs a Broad-Based Agreement for Use of Antibody Technologies …
MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co.,…
Go To Page:
